Sartorius Stedim Biotech Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	426.1	678.9	116.6	107.1	223.6
Short-Term Investments	8.1	9.9	9.5	24.8	12.7
Cash & Short-Term Investments	434.2	688.8	126.1	131.9	236.3
Cash Growth	-36.96%	446.23%	-4.40%	-44.18%	239.49%
Accounts Receivable	192.8	265.9	293.7	404.6	356
Other Receivables	31.5	33.8	39.8	14	14.7
Receivables	227.3	300.6	334.4	419.7	371.7
Inventory	690.9	684.9	882.4	1,025	783
Other Current Assets	88.8	66.7	72.2	94.8	64.6
Total Current Assets	1,441	1,741	1,415	1,671	1,456
Property, Plant & Equipment	1,431	1,163	1,036	808	640.2
Long-Term Investments	19	24	40.8	24.9	14.8
Goodwill	2,884	2,908	2,885	1,136	820.7
Other Intangible Assets	1,231	1,361	1,465	712.1	563.3
Long-Term Deferred Tax Assets	75.2	63.2	60	61.6	46.5
Long-Term Deferred Charges	303.8	269	227.8	164.2	120.9
Other Long-Term Assets	598.7	727.6	601	487	289.1
Total Assets	7,984	8,256	7,730	5,065	3,951
Accounts Payable	277.8	310	258.5	251.5	251.4
Accrued Expenses	99.1	88.2	62.3	74.1	97.2
Current Portion of Long-Term Debt	557.3	39.5	57.7	4.5	25.5
Current Portion of Leases	23.4	25	21.4	19.5	14.9
Current Income Taxes Payable	82	123.2	189.4	209.6	165
Current Unearned Revenue	167.6	216.1	238.6	271	259.6
Other Current Liabilities	204.9	136.8	109.4	205.7	223.5
Total Current Liabilities	1,412	938.8	937.3	1,036	1,037
Long-Term Debt	1,867	2,684	3,510	1,021	521.1
Long-Term Leases	151.2	120.6	93.1	91.1	64
Pension & Post-Retirement Benefits	38.8	39.3	34.6	35.6	46.8
Long-Term Deferred Tax Liabilities	375.6	358.2	389.4	178.3	125.8
Other Long-Term Liabilities	12.9	91.3	92.2	189.7	423
Total Liabilities	3,858	4,233	5,056	2,551	2,218
Common Stock	19.5	19.5	18.4	18.4	18.4
Retained Earnings	2,703	2,496	2,391	2,179	1,397
Comprehensive Income & Other	1,368	1,471	229	251.9	240.2
Total Common Equity	4,091	3,987	2,639	2,449	1,656
Minority Interest	35.6	37.2	35.3	64.9	77.4
Shareholders' Equity	4,126	4,024	2,674	2,514	1,733
Total Liabilities & Equity	7,984	8,256	7,730	5,065	3,951
Total Debt	2,599	2,870	3,682	1,136	625.5
Net Cash (Debt)	-2,165	-2,181	-3,556	-1,004	-389.2
Net Cash Per Share	-22.25	-22.53	-38.58	-10.89	-4.22
Filing Date Shares Outstanding	97.3	97.3	92.16	92.16	92.18
Total Common Shares Outstanding	97.3	97.3	92.16	92.16	92.18
Working Capital	29.1	802.2	477.8	635.3	418.5
Book Value Per Share	42.04	40.97	28.63	26.58	17.96
Tangible Book Value	-24.7	-282.4	-1,711	600.8	271.9
Tangible Book Value Per Share	-0.25	-2.90	-18.57	6.52	2.95
Land	1,023	803.1	707.8	509.1	426.2
Machinery	895.6	796.2	688.5	581.3	469.7
Order Backlog	1,308	1,482	1,495	1,844	1,915

Source: S&P Global Market Intelligence. Standard template. Financial Sources.